PATTERNS OF TREATMENT ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INITIATING LINAGLIPTIN AND OTHER NON-INSULIN DIABETES MEDICATIONS (NIDMS)

被引:0
|
作者
Patorno, E. [1 ,2 ]
Gopalakrishnan, C. [1 ,2 ]
Zorina, O. [3 ]
Schneeweiss, S. [1 ,2 ]
Bartels, D. [3 ]
Seeger, J. D. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
关键词
D O I
10.1016/j.jval.2015.03.335
中图分类号
F [经济];
学科分类号
02 ;
摘要
PDB28
引用
收藏
页码:A57 / A57
页数:1
相关论文
共 50 条
  • [21] Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)
    Fonseca, Vivian
    Dejager, Sylvie
    Albrecht, Diego
    Shirt, Lynda
    Schweizer, Anja
    DIABETES, 2006, 55 : A111 - A111
  • [22] Self-Reported Goals and Challenges of Dietary Adherence in Patients with Type 2 Diabetes Mellitus (T2DM)
    Traina, Shana B.
    Weiser, Jonathan D.
    DIABETES, 2010, 59 : A525 - A525
  • [23] THE COST-EFFECTIVENESS OF DAPAGLIFLOZIN IN COMBINATION WITH INSULIN FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN SPAIN
    Sanchez-Covisa, J.
    Capel, M.
    Schmidt, R.
    Charokopou, M.
    Verheggen, B. G.
    VALUE IN HEALTH, 2014, 17 (07) : A350 - A350
  • [24] HDL EFFLUX CAPACITY, AND PARTICLE REMODELLING IN PATIENTS WITH TYPE 1 DIABETES MELLITUS (T1DM) AND TYPE 2 DIABETES MELLITUS (T2DM)
    Byrne, R.
    Curley, S.
    Ahmed, K.
    Ahmed, M.
    Gibney, J.
    Mcgillicuddy, F.
    ATHEROSCLEROSIS, 2020, 315 : E65 - E66
  • [25] A Study To Assess the Metabolic Effects of Ranolazine When Added to Ongoing Non-Insulin Medical Therapy in Subjects with Type 2 Diabetes Mellitus (T2DM)
    Kipnes, Mark S.
    Bays, Harold E.
    Staehr, Peter
    Nath, Rajneesh
    Kwon, David S.
    Gottwald, Millie D.
    Belardinelli, Luiz
    DIABETES, 2011, 60 : A316 - A316
  • [26] Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in patients with type 2 diabetes mellitus (T2DM)
    Miyazaki, Y
    Mahankali, A
    Matsuda, M
    Mahankali, S
    Cusi, K
    Mandarino, L
    Defronzo, RA
    DIABETES, 2000, 49 : A299 - A299
  • [27] SPECIAL EFFECTS OF INSULIN REGIMEN (DISSIMILAR PROCEDURES) ON HOSPITALIZED PATIENTS OF TYPE 2 DIABETES MELLITUS (T2DM)
    Ahmad, Shakeel
    Kanwal, Samra
    Haider, Muhammad Haroon
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (08): : 8180 - +
  • [28] THE PREVALENCE OF MICROALBUMINURIA IN CHILDREN WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Yafi, Michael
    ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 : A250 - A250
  • [29] MODELING THE HEALTH AND ECONOMIC CONSEQENCES OF SELF-MONITORING OF BLOOD GLUCOSE (SMBG) IN NON-INSULIN TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN SPAIN
    Dirani, R.
    Diago-Cabezudo, J., I
    Willis, W.
    VALUE IN HEALTH, 2012, 15 (07) : A354 - A354
  • [30] Regional effects of type 2 diabetes mellitus (T2DM) on neurodegeneration
    Moran, C.
    Phan, T. G.
    Beare, R. J.
    Chen, J.
    Blizzard, L.
    Venn, A.
    Greenaway, T.
    Munch, G.
    Forbes, J.
    Pearson, S.
    Srikanth, V
    INTERNATIONAL JOURNAL OF STROKE, 2012, 7 : 20 - 20